Bullpen.News From Edwin Dorsey
Submit an Article

Tuesday, September 1, 2026

From X

@BrokenMoats 1 click

Broken Moats on X

$BSX ?? flat over the past 5 years. Can point to slowing growth from very elevated levels as farapulse and watchman have larger bases, some competition entering these spaces, glp1 on the margin to case loads over time, new inhibitors that could be coming from Lilly, novo, but at current $ sure seems like a lot is baked in at current prices. Innovative cardio franchise that has: Revenue has effectively doubled - predominately from farapulse and watchman (not m&a) Operating income 1.8B to 4.1B EBIT - $1.4B to 4.1B 3.5x on EPS (.69 to $2.40/share current) gross, operating, net, ebit, ebitda margins all expanded over that timeframe FCF more than 2x, opcf 2.5x The difference is you get to buy it at the same share price today, shares outstanding are virtually flat. Perhaps the defensive nature of medtech is sold in the aggressive risk on market we are in but growth still solid here with dividend and margin of safety versus other areas certainly seems worth a look, as is the rest of medtech as a place to hunt for value to wait until the market rotates back
@BrokenMoats 3 clicks

Broken Moats on X

Pretty incredible market sells off software again aggressively at the same time ramping up public private credit exposed names like $MFC, $ARES, $FG (CEO left suddenly yesterday) all because they ride alongside the aggressive buying in money center banks in financial etc flows ($JPM up 14% in June). Seems like there needs to be some dispersion in public private credit and software - one side at current prices has to be wrong, guessing private credit lower is how the dispersion resolves itself
@ActAccordingly

PAA Research on X

This is the "funding secured" moment for $SPCX. Will it matter for @elonmusk or the company? Probably not. We've been down this path before and the SEC blinked when there was a moment to enforce the rules we have in place with $TSLA. No question that no other executive gets away with this aside from Elon. This is a clear violation of the "quiet period" surrounding IPOs. To me the more interesting question is: why does Elon feel the need to provide 2030 guidance for his company a couple of days after the first trading day for $SPCX?

Investor Letters

All letters
BE 2026-08-29

Bloom Energy: 5 Links That Cannot Break

Bloom Energy’s 80x forward earnings valuation relies on concentrated megaprojects, sustained AI data-center power demand and continued…

BE $64B
Valuation Rewind 6 clicks

Publications we follow

Every publication on this site, hand-picked.

68 publications
Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

54 accounts
Nominate an account

Sectors

Ordered by how often our editor reaches for them.